BBA
TEVA icon

BLB&B Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

BLB&B Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,996
Closed -$334K – 315
2017
Q3 		$334K Sell
18,996
-8,910
-32% -$200K 0.05% 215
2017
Q2 		$927K Buy
27,906
+674
+2% +$20.9K 0.15% 130
2017
Q1 		$874K Buy
27,232
+650
+2% +$22.2K 0.15% 132
2016
Q4 		$964K Sell
26,582
-521
-2% -$20.8K 0.17% 127
2016
Q3 		$1.25M Buy
27,103
+1,128
+4% +$58.9K 0.23% 106
2016
Q2 		$1.3M Sell
25,975
-3
-0% -$160 0.25% 101
2016
Q1 		$1.39M Buy
25,978
+302
+1% +$17.7K 0.28% 96
2015
Q4 		$1.69M Sell
25,676
-898
-3% -$55.5K 0.36% 83
2015
Q3 		$1.5M Sell
26,574
-4,281
-14% -$278K 0.33% 88
2015
Q2 		$1.82M Sell
30,855
-1,220
-4% -$75.3K 0.38% 80
2015
Q1 		$2M Buy
32,075
+1,203
+4% +$69.9K 0.42% 72
2014
Q4 		$1.77M Buy
30,872
+202
+0.7% +$11.3K 0.38% 72
2014
Q3 		$1.65M Sell
30,670
-67
-0.2% -$3.55K 0.36% 75
2014
Q2 		$1.61M Sell
30,737
-100
-0.3% -$5.11K 0.34% 75
2014
Q1 		$1.63M Sell
30,837
-100
-0.3% -$4.62K 0.36% 72
2013
Q4 		$1.24M Sell
30,937
-254
-0.8% -$10K 0.3% 85
2013
Q3 		$1.18M Buy
31,191
+497
+2% +$19.4K 0.31% 81
2013
Q2 		$1.2M Buy
+30,694
New +$1.2M 0.33% 80

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

BLB&B Advisors's TEVA Position: Q4 2017 in Review

BLB&B Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 18,996 shares — an estimated $334K sold.

BLB&B Advisors first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $2M in Q1 2015. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • BLB&B Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • BLB&B Advisors sold 18,996 Teva Pharmaceuticals shares in Q4 2017, an estimated $334K.
  • BLB&B Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • BLB&B Advisors's Teva Pharmaceuticals position peaked at $2M in Q1 2015.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on BLB&B Advisors's 13F filing for Q4 2017, filed 16 Jan 2018.